Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Nanofluidic Diffraction Grating Technique for DNA Amplification May Replace PCR

By LabMedica International staff writers
Posted on 21 Sep 2016
A team of Japanese biophysicists suggests replacing the RT-PCR (real time polymerase chain reaction) technique with a rapid label-free detection method for real-time DNA amplification using a nanofluidic diffraction grating.

Investigators at Nagoya University (Japan) based their strategy for quantifying DNA amplification in a label-free manner on observations of intensity changes of diffracted light derived from the passage of a laser beam through nanochannels embedded in a microchannel; the ability to diffract the beam is a basic characteristic of nanochannels.

In practice, they fabricated 2.7 micron deep, 200 nanometer wide periodic nanochannels embedded in microchannels, which were etched on fused silica substrates by electron beam lithography, photolithography, and plasma etching. More...
For an incident laser beam they used a modulated 532 nanometer laser to amplify a specific component extracted from random or background noise.

They investigators reported in the August 17, 2016, online edition of the journal Scientific Reports that numerical simulations revealed that the diffracted light intensity change in the nanofluidic diffraction grating was attributed to the change of refractive index. Using the technique, they demonstrated the first case reported to date for label-free detection of real-time DNA amplification, such as specific DNA sequences from tubercle bacilli (TB) and human papillomavirus (HPV). Since the system allowed quantification of the initial concentration of amplified DNA molecules ranging from one femtomolar to one picomolar, the investigators expect that it will offer a new strategy for developing fundamental techniques of medical applications.

"Our system also measures DNA amplification at the relatively low temperature of 34 degrees Celsius and without the need for thermal cycles," said contributing author Dr. Noritada Kaji, associate professor of engineering at Nagoya University. "Because it has the potential to be constructed as a single chip and can detect sample volumes as small as one microliter, which is 100-1,000 times less than conventional detectors are capable of, it is particularly suited to development as a miniaturized form of diagnostics and microbe detection."

Related Links:
Nagoya University


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Immunofluorescence Analyzer
IFA System
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers from the Department of Chemistry at Aarhus University have developed and tested a new technology that can identify and measure the concentration of pharmaceuticals in under 10 minutes. Today, this process takes up to an hour. That is critical waiting time for patients suffering from a stroke. (Image Credit: Aarhus University)

Point-of-Care Blood Test Could Speed Treatment Decisions in Acute Stroke

Minutes can shape treatment decisions in emergency stroke care, particularly when physicians need to know whether a patient is taking anticoagulants before administering clot-dissolving therapy.... Read more

Microbiology

view channel
Image: The clearance also broadens QIAstat-Dx\'s infectious disease testing menu in the U.S., which already includes panels for respiratory and gastrointestinal infections, as well as meningitis and encephalitis (Photo courtesy of Qiagen)

One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens

Bloodstream infections can progress rapidly and lead to sepsis, organ failure, and death. In the United States, about 1.7 million adults develop sepsis each year, and at least 350,000 die during hospitalization... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.